USA Neurometabolic Disorders Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report offers an overview of the market trends, drivers, and barriers with respect to the USA Neurometabolic Disorders market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Neurometabolic Disorders market. Detailed analysis of key players, along with key growth strategies adopted by Neurometabolic Disorders industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • Greencross

    • Lixte Biotechnology

    • Biomarin

    • Genzyme

    • ExSAR Corporation

    • Neuraltus Pharmaceuticals

    • Protalix BioTherapeutics

    • Dong-A Socio Group

    • Amicus Therapeutics

    • JCR Pharmaceuticals

    • ISU Abxis

    • Protalix

    • Greenovation Biotech

    • Shire

    • Biosidus

    • Shire BioTherapeutics

    • Pharming Group

    • Amicus

    By Type:

    • Gaucher’s Disease

    • Fabry Disease

    • Pompe Disease

    • Mucopolysaccharidosis VI

    • Other

    By End-User:

    • Oral

    • Parenteral

    By Region:

    • West USA

    • South USA

    • Middle West USA

    • Northeast USA

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Neurometabolic Disorders Market

    • 1.3 Market Segment by Type

      • 1.3.1 USA Neurometabolic Disorders Market Size and Growth Rate of Gaucher’s Disease from 2016 to 2027

      • 1.3.2 USA Neurometabolic Disorders Market Size and Growth Rate of Fabry Disease from 2016 to 2027

      • 1.3.3 USA Neurometabolic Disorders Market Size and Growth Rate of Pompe Disease from 2016 to 2027

      • 1.3.4 USA Neurometabolic Disorders Market Size and Growth Rate of Mucopolysaccharidosis VI from 2016 to 2027

      • 1.3.5 USA Neurometabolic Disorders Market Size and Growth Rate of Other from 2016 to 2027

    • 1.4 Market Segment by Application

      • 1.4.1 USA Neurometabolic Disorders Market Size and Growth Rate of Oral from 2016 to 2027

      • 1.4.2 USA Neurometabolic Disorders Market Size and Growth Rate of Parenteral from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 West USA Neurometabolic Disorders Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 South USA Neurometabolic Disorders Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 Middle West USA Neurometabolic Disorders Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 Northeast USA Neurometabolic Disorders Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Neurometabolic Disorders Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Neurometabolic Disorders by Major Types

      • 3.4.1 Market Size and Growth Rate of Gaucher’s Disease

      • 3.4.2 Market Size and Growth Rate of Fabry Disease

      • 3.4.3 Market Size and Growth Rate of Pompe Disease

      • 3.4.4 Market Size and Growth Rate of Mucopolysaccharidosis VI

      • 3.4.5 Market Size and Growth Rate of Other

    4 Segmentation of Neurometabolic Disorders Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Neurometabolic Disorders by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Neurometabolic Disorders in Oral

      • 4.4.2 Market Size and Growth Rate of Neurometabolic Disorders in Parenteral

    5 Market Analysis by Regions

    • 5.1 USA Neurometabolic Disorders Production Analysis by Regions

    • 5.2 USA Neurometabolic Disorders Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on USA Economy

    6 West USA Neurometabolic Disorders Landscape Analysis

    • 6.1 West USA Neurometabolic Disorders Landscape Analysis by Major Types

    • 6.2 West USA Neurometabolic Disorders Landscape Analysis by Major End-Users

    7 South USA Neurometabolic Disorders Landscape Analysis

    • 7.1 South USA Neurometabolic Disorders Landscape Analysis by Major Types

    • 7.2 South USA Neurometabolic Disorders Landscape Analysis by Major End-Users

    8 Middle West USA Neurometabolic Disorders Landscape Analysis

    • 8.1 Middle West USA Neurometabolic Disorders Landscape Analysis by Major Types

    • 8.2 Middle West USA Neurometabolic Disorders Landscape Analysis by Major End-Users

    9 Northeast USA Neurometabolic Disorders Landscape Analysis

    • 9.1 Northeast USA Neurometabolic Disorders Landscape Analysis by Major Types

    • 9.2 Northeast USA Neurometabolic Disorders Landscape Analysis by Major End-Users

    10 Major Players Profiles

      • 10.1 Greencross

        • 10.1.1 Greencross Company Profile and Recent Development

        • 10.1.2 Market Performance

        • 10.1.3 Product and Service Introduction

      • 10.2 Lixte Biotechnology

        • 10.2.1 Lixte Biotechnology Company Profile and Recent Development

        • 10.2.2 Market Performance

        • 10.2.3 Product and Service Introduction

      • 10.3 Biomarin

        • 10.3.1 Biomarin Company Profile and Recent Development

        • 10.3.2 Market Performance

        • 10.3.3 Product and Service Introduction

      • 10.4 Genzyme

        • 10.4.1 Genzyme Company Profile and Recent Development

        • 10.4.2 Market Performance

        • 10.4.3 Product and Service Introduction

      • 10.5 ExSAR Corporation

        • 10.5.1 ExSAR Corporation Company Profile and Recent Development

        • 10.5.2 Market Performance

        • 10.5.3 Product and Service Introduction

      • 10.6 Neuraltus Pharmaceuticals

        • 10.6.1 Neuraltus Pharmaceuticals Company Profile and Recent Development

        • 10.6.2 Market Performance

        • 10.6.3 Product and Service Introduction

      • 10.7 Protalix BioTherapeutics

        • 10.7.1 Protalix BioTherapeutics Company Profile and Recent Development

        • 10.7.2 Market Performance

        • 10.7.3 Product and Service Introduction

      • 10.8 Dong-A Socio Group

        • 10.8.1 Dong-A Socio Group Company Profile and Recent Development

        • 10.8.2 Market Performance

        • 10.8.3 Product and Service Introduction

      • 10.9 Amicus Therapeutics

        • 10.9.1 Amicus Therapeutics Company Profile and Recent Development

        • 10.9.2 Market Performance

        • 10.9.3 Product and Service Introduction

      • 10.10 JCR Pharmaceuticals

        • 10.10.1 JCR Pharmaceuticals Company Profile and Recent Development

        • 10.10.2 Market Performance

        • 10.10.3 Product and Service Introduction

      • 10.11 ISU Abxis

        • 10.11.1 ISU Abxis Company Profile and Recent Development

        • 10.11.2 Market Performance

        • 10.11.3 Product and Service Introduction

      • 10.12 Protalix

        • 10.12.1 Protalix Company Profile and Recent Development

        • 10.12.2 Market Performance

        • 10.12.3 Product and Service Introduction

      • 10.13 Greenovation Biotech

        • 10.13.1 Greenovation Biotech Company Profile and Recent Development

        • 10.13.2 Market Performance

        • 10.13.3 Product and Service Introduction

      • 10.14 Shire

        • 10.14.1 Shire Company Profile and Recent Development

        • 10.14.2 Market Performance

        • 10.14.3 Product and Service Introduction

      • 10.15 Biosidus

        • 10.15.1 Biosidus Company Profile and Recent Development

        • 10.15.2 Market Performance

        • 10.15.3 Product and Service Introduction

      • 10.16 Shire BioTherapeutics

        • 10.16.1 Shire BioTherapeutics Company Profile and Recent Development

        • 10.16.2 Market Performance

        • 10.16.3 Product and Service Introduction

      • 10.17 Pharming Group

        • 10.17.1 Pharming Group Company Profile and Recent Development

        • 10.17.2 Market Performance

        • 10.17.3 Product and Service Introduction

      • 10.18 Amicus

        • 10.18.1 Amicus Company Profile and Recent Development

        • 10.18.2 Market Performance

        • 10.18.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure USA Neurometabolic Disorders Market Size and Growth Rate of Gaucher’s Disease from 2016 to 2027

    • Figure USA Neurometabolic Disorders Market Size and Growth Rate of Fabry Disease from 2016 to 2027

    • Figure USA Neurometabolic Disorders Market Size and Growth Rate of Pompe Disease from 2016 to 2027

    • Figure USA Neurometabolic Disorders Market Size and Growth Rate of Mucopolysaccharidosis VI from 2016 to 2027

    • Figure USA Neurometabolic Disorders Market Size and Growth Rate of Other from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2020

    • Figure Market Share by Type in 2027

    • Figure USA Neurometabolic Disorders Market Size and Growth Rate of Oral from 2016 to 2027

    • Figure USA Neurometabolic Disorders Market Size and Growth Rate of Parenteral from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2020

    • Figure Market Share by End-User in 2027

    • Figure West USA Neurometabolic Disorders Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South USA Neurometabolic Disorders Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Middle West USA Neurometabolic Disorders Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast USA Neurometabolic Disorders Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Neurometabolic Disorders Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2019

    • Figure Market Share of TOP 5 Players in 2019

    • Figure Market Share of TOP 6 Players from 2016 to 2020

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Distribution Map of USA

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Neurometabolic Disorders

    • Figure Development Trends of Different Types

    • Table Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Neurometabolic Disorders by Different Types from 2016 to 2027

    • Table Consumption Share of Neurometabolic Disorders by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of Gaucher’s Disease

    • Figure Market Size and Growth Rate of Fabry Disease

    • Figure Market Size and Growth Rate of Pompe Disease

    • Figure Market Size and Growth Rate of Mucopolysaccharidosis VI

    • Figure Market Size and Growth Rate of Other

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Neurometabolic Disorders by Different End-Users from 2016 to 2027

    • Table Consumption Share of Neurometabolic Disorders by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Oral

    • Figure Market Size and Growth Rate of Parenteral

    • Table USA Neurometabolic Disorders Production by Regions

    • Table USA Neurometabolic Disorders Production Share by Regions

    • Figure USA Neurometabolic Disorders Production Share by Regions in 2016

    • Figure USA Neurometabolic Disorders Production Share by Regions in 2021

    • Figure USA Neurometabolic Disorders Production Share by Regions in 2027

    • Table USA Neurometabolic Disorders Consumption by Regions

    • Table USA Neurometabolic Disorders Consumption Share by Regions

    • Figure USA Neurometabolic Disorders Consumption Share by Regions in 2016

    • Figure USA Neurometabolic Disorders Consumption Share by Regions in 2021

    • Figure USA Neurometabolic Disorders Consumption Share by Regions in 2027

    • Table West USA Neurometabolic Disorders Consumption by Types from 2016 to 2027

    • Table West USA Neurometabolic Disorders Consumption Share by Types from 2016 to 2027

    • Figure West USA Neurometabolic Disorders Consumption Share by Types in 2016

    • Figure West USA Neurometabolic Disorders Consumption Share by Types in 2021

    • Figure West USA Neurometabolic Disorders Consumption Share by Types in 2027

    • Table West USA Neurometabolic Disorders Consumption by End-Users from 2016 to 2027

    • Table West USA Neurometabolic Disorders Consumption Share by End-Users from 2016 to 2027

    • Figure West USA Neurometabolic Disorders Consumption Share by End-Users in 2016

    • Figure West USA Neurometabolic Disorders Consumption Share by End-Users in 2021

    • Figure West USA Neurometabolic Disorders Consumption Share by End-Users in 2027

    • Table South USA Neurometabolic Disorders Consumption by Types from 2016 to 2027

    • Table South USA Neurometabolic Disorders Consumption Share by Types from 2016 to 2027

    • Figure South USA Neurometabolic Disorders Consumption Share by Types in 2016

    • Figure South USA Neurometabolic Disorders Consumption Share by Types in 2021

    • Figure South USA Neurometabolic Disorders Consumption Share by Types in 2027

    • Table South USA Neurometabolic Disorders Consumption by End-Users from 2016 to 2027

    • Table South USA Neurometabolic Disorders Consumption Share by End-Users from 2016 to 2027

    • Figure South USA Neurometabolic Disorders Consumption Share by End-Users in 2016

    • Figure South USA Neurometabolic Disorders Consumption Share by End-Users in 2021

    • Figure South USA Neurometabolic Disorders Consumption Share by End-Users in 2027

    • Table Middle West USA Neurometabolic Disorders Consumption by Types from 2016 to 2027

    • Table Middle West USA Neurometabolic Disorders Consumption Share by Types from 2016 to 2027

    • Figure Middle West USA Neurometabolic Disorders Consumption Share by Types in 2016

    • Figure Middle West USA Neurometabolic Disorders Consumption Share by Types in 2021

    • Figure Middle West USA Neurometabolic Disorders Consumption Share by Types in 2027

    • Table Middle West USA Neurometabolic Disorders Consumption by End-Users from 2016 to 2027

    • Table Middle West USA Neurometabolic Disorders Consumption Share by End-Users from 2016 to 2027

    • Figure Middle West USA Neurometabolic Disorders Consumption Share by End-Users in 2016

    • Figure Middle West USA Neurometabolic Disorders Consumption Share by End-Users in 2021

    • Figure Middle West USA Neurometabolic Disorders Consumption Share by End-Users in 2027

    • Table Northeast USA Neurometabolic Disorders Consumption by Types from 2016 to 2027

    • Table Northeast USA Neurometabolic Disorders Consumption Share by Types from 2016 to 2027

    • Figure Northeast USA Neurometabolic Disorders Consumption Share by Types in 2016

    • Figure Northeast USA Neurometabolic Disorders Consumption Share by Types in 2021

    • Figure Northeast USA Neurometabolic Disorders Consumption Share by Types in 2027

    • Table Northeast USA Neurometabolic Disorders Consumption by End-Users from 2016 to 2027

    • Table Northeast USA Neurometabolic Disorders Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast USA Neurometabolic Disorders Consumption Share by End-Users in 2016

    • Figure Northeast USA Neurometabolic Disorders Consumption Share by End-Users in 2021

    • Figure Northeast USA Neurometabolic Disorders Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of Greencross

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Greencross

    • Figure Sales and Growth Rate Analysis of Greencross

    • Figure Revenue and Market Share Analysis of Greencross

    • Table Product and Service Introduction of Greencross

    • Table Company Profile and Development Status of Lixte Biotechnology

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Lixte Biotechnology

    • Figure Sales and Growth Rate Analysis of Lixte Biotechnology

    • Figure Revenue and Market Share Analysis of Lixte Biotechnology

    • Table Product and Service Introduction of Lixte Biotechnology

    • Table Company Profile and Development Status of Biomarin

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Biomarin

    • Figure Sales and Growth Rate Analysis of Biomarin

    • Figure Revenue and Market Share Analysis of Biomarin

    • Table Product and Service Introduction of Biomarin

    • Table Company Profile and Development Status of Genzyme

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Genzyme

    • Figure Sales and Growth Rate Analysis of Genzyme

    • Figure Revenue and Market Share Analysis of Genzyme

    • Table Product and Service Introduction of Genzyme

    • Table Company Profile and Development Status of ExSAR Corporation

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of ExSAR Corporation

    • Figure Sales and Growth Rate Analysis of ExSAR Corporation

    • Figure Revenue and Market Share Analysis of ExSAR Corporation

    • Table Product and Service Introduction of ExSAR Corporation

    • Table Company Profile and Development Status of Neuraltus Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Neuraltus Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Neuraltus Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Neuraltus Pharmaceuticals

    • Table Product and Service Introduction of Neuraltus Pharmaceuticals

    • Table Company Profile and Development Status of Protalix BioTherapeutics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Protalix BioTherapeutics

    • Figure Sales and Growth Rate Analysis of Protalix BioTherapeutics

    • Figure Revenue and Market Share Analysis of Protalix BioTherapeutics

    • Table Product and Service Introduction of Protalix BioTherapeutics

    • Table Company Profile and Development Status of Dong-A Socio Group

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Dong-A Socio Group

    • Figure Sales and Growth Rate Analysis of Dong-A Socio Group

    • Figure Revenue and Market Share Analysis of Dong-A Socio Group

    • Table Product and Service Introduction of Dong-A Socio Group

    • Table Company Profile and Development Status of Amicus Therapeutics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Amicus Therapeutics

    • Figure Sales and Growth Rate Analysis of Amicus Therapeutics

    • Figure Revenue and Market Share Analysis of Amicus Therapeutics

    • Table Product and Service Introduction of Amicus Therapeutics

    • Table Company Profile and Development Status of JCR Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of JCR Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of JCR Pharmaceuticals

    • Figure Revenue and Market Share Analysis of JCR Pharmaceuticals

    • Table Product and Service Introduction of JCR Pharmaceuticals

    • Table Company Profile and Development Status of ISU Abxis

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of ISU Abxis

    • Figure Sales and Growth Rate Analysis of ISU Abxis

    • Figure Revenue and Market Share Analysis of ISU Abxis

    • Table Product and Service Introduction of ISU Abxis

    • Table Company Profile and Development Status of Protalix

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Protalix

    • Figure Sales and Growth Rate Analysis of Protalix

    • Figure Revenue and Market Share Analysis of Protalix

    • Table Product and Service Introduction of Protalix

    • Table Company Profile and Development Status of Greenovation Biotech

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Greenovation Biotech

    • Figure Sales and Growth Rate Analysis of Greenovation Biotech

    • Figure Revenue and Market Share Analysis of Greenovation Biotech

    • Table Product and Service Introduction of Greenovation Biotech

    • Table Company Profile and Development Status of Shire

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Shire

    • Figure Sales and Growth Rate Analysis of Shire

    • Figure Revenue and Market Share Analysis of Shire

    • Table Product and Service Introduction of Shire

    • Table Company Profile and Development Status of Biosidus

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Biosidus

    • Figure Sales and Growth Rate Analysis of Biosidus

    • Figure Revenue and Market Share Analysis of Biosidus

    • Table Product and Service Introduction of Biosidus

    • Table Company Profile and Development Status of Shire BioTherapeutics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Shire BioTherapeutics

    • Figure Sales and Growth Rate Analysis of Shire BioTherapeutics

    • Figure Revenue and Market Share Analysis of Shire BioTherapeutics

    • Table Product and Service Introduction of Shire BioTherapeutics

    • Table Company Profile and Development Status of Pharming Group

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pharming Group

    • Figure Sales and Growth Rate Analysis of Pharming Group

    • Figure Revenue and Market Share Analysis of Pharming Group

    • Table Product and Service Introduction of Pharming Group

    • Table Company Profile and Development Status of Amicus

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Amicus

    • Figure Sales and Growth Rate Analysis of Amicus

    • Figure Revenue and Market Share Analysis of Amicus

    • Table Product and Service Introduction of Amicus


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.